Genscript Biotech Corporation (SEHK:1548) entered into a stock purchase agreement to acquire CustomArray, Inc. on December 25, 2017. Under the terms of the transaction, Genscript will acquire 100% of the entire issued shares of CustomArray. Post-acquisition, the entire CustomArray team will join Genscript. The transaction is subject to customary closing conditions. Charles Chau of Jones Day acted as legal advisor for the buyer. Genscript Biotech Corporation (SEHK:1548) completed the acquisition of CustomArray, Inc. on January 11, 2018.